ALECENSA Drug Use Surveillance

ALECENSA Drug Use Surveillance - ALECENSA Drug Use Surveillance

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014989

Enrollment

1000

Registered

2014-09-05

Start date

2014-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who are scheduled to receive ALECENSA at contracted institutions during this surveillance's enrollment period.

Exclusion criteria

Exclusion criteria: No criteria

Design outcomes

Primary

Measure	Time frame
Safety; ADR occurrence	—

Secondary

Measure	Time frame
Efficacy; Tabulation of patient outcomes (survival/death), calculation of one-year survival rate	—

Countries

Japan

Contacts

Public ContactAyaka Shimizu

Chugai Pharmaceutical Co. Ltd. Real World Data Science Dept.

shimizuayk@chugai-pharm.co.jp03-3273-0905

Outcome results